XML 105 R94.htm IDEA: XBRL DOCUMENT
v3.5.0.2

CONCENTRATIONS (Details) - USD ($) | 12 Months Ended
--- | ---
Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013
Concentration Risk [Line Items] |  |  |
Total Revenues | $ 1,686,033 | $ 17,686,049 | $ 16,858,178
Less: revenues from discontinued operations | (364,490) | (14,911,808) | (9,455,705)
Revenues from continuing operations | 1,321,543 | 2,774,241 | 7,402,473
Medical Devices [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Total Revenues | 1,500,957 | 16,000,881 | 14,824,028
Respiratory and Oxygen Homecare [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Total Revenues | 20,573 | 53,755 | 2,034,150
Mobile medicine [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Total Revenues | $ 164,503 | $ 1,631,413 | $ 0

X
- Definition Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation. + References No definition available. + Details
Name: | dhrm_RevenuesDiscontinuedOperation
Namespace Prefix: | dhrm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ConcentrationRiskLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of regulated steam operating revenues recognized during the period. + References No definition available. + Details
Name: | us-gaap_RegulatedOperatingRevenueSteam
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhrm_MedicalDevicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhrm_RespiratoryAndOxygenHomecareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhrm_MobileMedicineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |